On December 4 and December 5, the 24^th China Pharmaceutical Company Marketing Summit Forum and 2013 Ten Best Prescription Medicine Award were held in Guangzhou. Leaders from state ministries and commissions, experts from different industries, senior managers from pharmaceutical companies attended the events and exchanged views on the status quo of pharmaceutical industry, quality control of pharmaceutical products and research and development. One of YRPG's Star Products, Jialuoning (Dizocine Injection), won 2013 Ten Best Pharmaceutical Company Marketing Achievements, Lusu (Rupatadine Fumarate Tablets) won 2013 Ten Best Prescription Medicines Award.
Dizocine Injection is a highly effective opioid pain-relieving medicine to address pain. It is effective, durable, safe with low reliance to users. Since its release in 2009, it has won wide market acclamation for its effectiveness, steadiness and soothing effect.
Rupatadine Fumarate Tablet is used to address chronic allergic rhinitis and hay fever. It can protect the lung from acute lung injuries and reverse pulmonaryfibrosisby adjusting the immune response without side effects such as poisoning on cardiovascular system or potential arrhythmia.
In recent years, Yangtze River Pharmaceutical Group is sticking to high quality, innovation, benefiting the public and enterprising values, introducing international advanced management model, enhancing quality system, intensify research and innovation, accelerating the transformation from "generic as mainstay" to "a combination of generics and innovation". Some of the Group's products have topped the list in domestic market and is heading fast to international market.